PHYLIS MUTHEE: Open Payments
NPI 1598015919 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 21 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $332 · 2025 $1,012
Food & beverage: $1,012
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $168 |
| Novo Nordisk Inc | 8 | $151 |
| Edwards Lifesciences Corporation | 1 | $135 |
| ABBVIE INC. | 2 | $131 |
| ViiV Healthcare Company | 1 | $118 |
| ALK-Abello, Inc | 1 | $114 |
| AstraZeneca Pharmaceuticals LP | 1 | $99 |
| Lilly USA, LLC | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $22 |
Products named: EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), VRAYLAR, Yeztugo, APRETUDE, AIRSUPRA, Wegovy, Ozempic, Kerendia.
Industry payments across WA — which companies pay providers there.
